Odyssey Health, Inc.
ODYY
$0.0081
-$0.0003-3.57%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -77.05% | -54.48% | -57.83% | -42.16% | -46.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -76.78% | -52.15% | -58.41% | -52.05% | -53.62% |
| Operating Income | 76.78% | 52.15% | 58.41% | 52.05% | 53.62% |
| Income Before Tax | -239.27% | 69.29% | 85.77% | 255.85% | 219.21% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -239.27% | 69.29% | 85.77% | 255.85% | 219.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -239.27% | 69.29% | 85.77% | 255.85% | 219.21% |
| EBIT | 76.78% | 52.15% | 58.41% | 52.05% | 53.62% |
| EBITDA | 76.78% | 52.13% | 58.41% | 52.06% | 53.65% |
| EPS Basic | -226.23% | 108.27% | 110.28% | 240.80% | 205.46% |
| Normalized Basic EPS | 77.85% | 58.24% | 57.08% | 50.39% | 50.15% |
| EPS Diluted | -292.76% | 51.73% | 63.69% | 194.07% | 168.53% |
| Normalized Diluted EPS | 76.62% | 63.07% | 60.96% | 53.67% | 52.76% |
| Average Basic Shares Outstanding | 22.45% | 22.37% | 15.25% | 7.96% | 1.57% |
| Average Diluted Shares Outstanding | 15.00% | 29.03% | 21.93% | 14.55% | 8.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |